Doherty Clinical Trials

Home
Australia
Melbourne, VIC
Doherty Clinical Trials

Dedicated to delivering innovative, safe and ethically-sound trials in a range of therapeutic areas.

17/07/2025

We’re proud to have started an important patient trial for a potential treatment for Friedreich ataxia at Doherty Clinical Trials! As a core part of our mission, we’re honoured to support the development of new potential treatments for medical conditions that currently lack safe and effective treatments, so that we may be able to improve health outcomes for current patients and future generations. We sincerely thank our patients and participants for their support. Well done to our amazing clinical, operations and laboratory team pictured here!

20/05/2025

Today is International Clinical Trials Day! With this year's theme, at Doherty Clinical Trials, we recognise and celebrate the contributions of our community to advancing medical research. Our studies’ participants, doctors, nurses, researchers and support staff are all powered by purpose: to improve the lives of patients and to create a healthier society for generations to come. Sincere thank you to our participants and staff!

08/04/2025

Did you know? Human infection challenge studies can generate critical scientific insights and have the aim of making potential treatments for infectious diseases more rapidly available to communities globally.

Human infection challenge trials involve exposing healthy volunteer participants to a well-characterised infectious agent (such as a bacteria or virus) in a controlled environment. A well-characterised infectious agent means that “the bug” has been tested for safety in humans and this has been approved by our Ethics Committee. When testing a new vaccine or treatment, “the bug” is applied either after the volunteer has been vaccinated, or before they have received treatment.

People who take part in human challenge trials play an important role in advancing infectious disease research.

Want to learn more and get involved? Visit our website: https://www.dohertyclinicaltrials.com/about/challenge-trials

06/03/2025

Ahead of International Women's Day, we would like to reflect on this year's theme, March Forward. As a relatively new clinical trial unit, we follow in the footsteps of those who came before us and we draw strength from the progress made by women who have advanced workplace rights and driven medical innovations. We also recognise the work that remains to be done to achieve gender equality. We are committed to taking strides within our organisation to be a part in creating a future where all women and girls entering the world of medical research can thrive in an environment of equality and opportunity.

12/09/2024

Doherty Clinical Trials is calling on healthy volunteers to participate in a new Phase I clinical trial of a needle-free vaccine for avian influenza. The trial will assess the safety and tolerability of the influenza vaccine administered using the needle-free technology developed by Australian biotech company, Vaxxas.

Unlike traditional needle and syringe administration, which is injected into a muscle, Vaxxas’ High-Density Microarray Patch (HD-MAP) technology delivers the vaccine to the immune cells immediately below the skin surface.

Doherty Clinical Trials’ Chief Medical Officer, Professor James McCarthy said: “This new way of delivering vaccines, such as influenza, is very exciting as it could reduce some of the limitations associated with vaccination via traditional methods.”

🔗 Learn more via news & events and register your interest at dohertyclinicaltrials.com

04/09/2024

Doherty Clinical Trials are proud to support the Blue Dragon Children's Foundation and as such, we’re getting behind some of the DCT team who will be tackling the Blue Dragon Marathon Walk this Sunday to raise funds for their vital work.

For over 20 years, Blue Dragon has been a leading agency in Vietnam’s fight against human trafficking, working tirelessly to not only reduce human trafficking, but to end it. Blue Dragon helps rescue women and children who have been trafficked and provides street kids access to medical care, food and education.

The Blue Dragon Marathon Walk takes place this Sunday, 8th September with members of the DCT team covering a whopping 42 kilometers. With Intrepid covering 100% of the administrative costs, every cent donated to their cause will go directly to helping youth in Vietnam.

We're right behind you Ivy, Nicola, Elaine and Thu-Anh! 💪❤

To read more about the Blue Dragon Children’s Foundation and to support our marathon walkers, visit t.ly/LPOo6

29/08/2024

Curious about what you can expect during the patient screening process?

All our clinical trials have strict criteria for patients and as such, all participants will undertake a screening process before commencement to ensure both participant and trial suitability.

To understand more about our patient screening process, visit us at dohertyclinicaltrials.com.

We look forward to meeting you and supporting ethical, medical research together.

17/07/2024

Refer a friend to Doherty Clinical Trials and once they have participated in a study with us, you’ll receive a $500 referral bonus. It’s that easy.

You’ll be making a positive difference to health outcomes, supporting ethical medical research and unlocking additional income. That’s a win/win if you ask us!

Visit dohertyclinicaltrials.com/refer-a-friend to find out more.

19/06/2024

"I really enjoyed having the opportunity to participate in this study. The team were so friendly and I always felt my needs were top priority. Thanks team!"

At Doherty Clinical Trials, we pride ourselves on our participant experience and our team will always go above and beyond to make sure your needs are met.

Register to participate in our upcoming studies at the link in bio. 🔗

06/06/2024

Doherty Clinical Trials was featured on Channel 7's last week, including interviews with Professor James McCarthy and Dr. Andrew Brockway, as well as some of our previous trial participants discussing the importance of our work in pandemic preparedness and explaining what's involved in clinical trials at our facility.

Sharing the significance of clinical research and explaining the ethics and safety mechanisms we have in place; the feature shares valuable insight into what you can expect from those who have participated in clinical trials themselves.

🔗 Watch the full feature at https://www.youtube.com/watch?v=MfgbQWjbUJQ

31/05/2024

The biggest biotech conference in the world is about to commence next week in San Diego; BIO International!

This is a great opportunity to continue to develop the outstanding reputation that Australia has for delivery of early phase trials. Our CEO, Andrew Brockway will be attending and is looking forward to discussing your clinical development plans.

Doherty Clinical Trials focuses on infectious disease clinical trials, from phase 1 – 3, including specialisation in human challenge models.

Please reach out via our website or through the BIO partnering platform. We look forward to discussing how we can support your clinical development progress!

20/05/2024

This International Clinical Trials Day, the team at Doherty Clinical Trials would like to acknowledge and thank all the participants who have given their time to support such vital work, both at Doherty Clinical Trials and the world over.

Without your support, the advancements in medical research that we have today, which has led to the eradication of diseases, the developments of vaccines and further integral research and understanding into therapies and treatments, would not have been possible.

In the words of ACRP - Association of Clinical Research Professionals, you really are the trailblazers among us.

Thank you.

Address

Melbourne, VIC

Website

http://www.dohertyclinicaltrials.com/

Alerts

Be the first to know and let us send you an email when Doherty Clinical Trials posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Doherty Clinical Trials: